Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised miceChloe Sligar, Debbie Watson, Peter Cuthbertson et al.|Clinical & Translational Immunology|2024Cited by 5